ATAndrey S. Tereshchenko

Andrey S. Tereshchenko

*This is an algorithmically generated author record based on publicly available information.

Andrey S. Tereshchenko has a total of 188 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    STAGED MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY ARTERY DISEASE BASED ON CORONARY PHYSIOLOGY PARAMETERS IN NON-INFARCT-RELATED ARTERIES: ANALYSIS OF OUTCOMES ACCORDING TO MID-TERM FOLLOW-UP

    by Khava U. Ibragimova, Tatiana S. Sukhinina, Goar K. Arutyunyan, Victoria A. Klyagina, Irina N. Merkulova, Vsevolod M. Mironov, Nikita S. Grishin, Andrey S. Tereshchenko, Evgeny V. Merkulov, Dmitry V. Pevzner, et al.

    Highlights The study demonstrates that in patients with uncomplicated STEMI and intermediate stenoses of non-infarct-related arteries, performing staged complete revascularization only with a hemodynamically significant fractional flow reserve (FFR) value ≤ 0.80 at 30–45 days after primary intervention is associated with no cases of cardiovascular death and recurrent myocardial infarction over a median follow-up of 21 months. The uniqueness of the approach lies in the selection of hemodynamically significant stenoses, which avoided excessive stenting in 40% of patients without worsening prognosis. Thus, the work makes an important contribution to the rationale for FFR-guided staged complete revascularization in STEMI patients with multivessel coronary artery disease. Aim. To evaluate the incidence of major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease after staged complete revascularization of non-infarct-related arteries (non-IRAs) guided by fractional flow reserve (FFR). Methods. This single-center prospective study included 52 patients with STEMI and intermediate non-IRA stenoses (50–85%). All patients underwent primary percutaneous coronary intervention of the infarct-related artery. At 30–45 days, FFR assessment in non-IRAs was performed; revascularization was performed when FFR ≤ 0.80. Median follow-up was 21 months. The primary endpoint was cardiovascular death and recurrent myocardial infarction. Results. Hemodynamically significant stenoses were identified in 31 patients (59.6%), who underwent stenting; 21 patients (40.4%) received only medical therapy. During the follow-up period, no cases of cardiovascular death or recurrent myocardial infarction were recorded (0%; 95% CI 0.0–5.6%). Repeat revascularization was performed in 4 patients (7.7%), and 2 cases of non-cardiovascular death (3.8%) were recorded. No cases of contrast-induced nephropathy, clinically significant bleeding, or stroke were observed. Conclusion. In patients with uncomplicated STEMI and intermediate non-IRA stenoses, an FFR-guided staged complete revascularization strategy performed at 30–45 days after primary intervention was associated with a low incidence of cardiovascular events; no cases of cardiovascular death or recurrent myocardial infarction were recorded in this cohort. This approach avoids excessive stenting but requires confirmation in larger studies.

  • Open Access

    Post-infarction ventricular septal rupture: short-term outcomes. Seven-year Russian single-center experience

    by E. A. Avetisyan, D. V. Pevzner, I. A. Merkulova, A. K. Alieva, L. O. Dulaev, I. T. Zyuryaev, A. D. Levshukov, E. V. Merkulov, A. G. Osiev, A. S. Tereshchenko, et al.

    Aim . To evaluate short-term clinical and procedural outcomes in patients with post-infarction ventricular septal rupture (PIVSR). Material and methods . This single-center, retrospective, non-randomized, observational cohort study included patients with PIVSR admitted to the Chazov National Medical Research Center of Cardiology in Moscow between 2019 and 2025. The analysis was conducted according to the type of procedure performed. The primary endpoint was any-cause inhospital mortality, with secondary endpoints including inhospital cardiovascular mortality and the rate of technical and procedural success after curative treatment. Results . In the period 2019-2025, the study included 94 patients with PIVSR (mean age, 68,5±12 years women, 56,4%). Open surgical repair was performed in 35,1% (33/94) of patients, while percutaneous closure (PC) — in 50,0% (47/94), conservative treatment — in 12,8% (12/94), and heart transplantation or implantation of a long-term left ventricular assist device with immediate open surgical repair. Secondary open surgical repair after PC was performed in 14,9% (7/47) of patients. Cardiogenic shock occurred in 62,8% (59/94) of patients: in the open surgical repair group — in 36,4% (12/33), in the PC group — in 83% (39/47). Mechanical circulatory support was used in 53,2% (50/94) of cases. Any-cause inhospital mortality was 53,3% (49/92): 74,5% (35/47) with PC, and 21,2% (7/33) with open surgical repair, and 58,3% (7/12) with conservative treatment. In the general group, 34,8% (32/92) of patients died from cardiovascular causes. In the open surgical repair and PC groups, technical success was achieved in 97,5% and 87,2%, and procedural success — in 72,7% and 51,1%, respectively. Conclusion . Approximately half of patients with PIVSR survive to discharge with a comprehensive treatment approach. In our center’s experience, various curative treatment methods complement each other and are used in patient populations with different clinical severity. The results highlight the need for further research aimed at optimizing the strategy, specifically the choice of intervention type and timing, and the use of mechanical circulatory support.

  • Open Access

    Patient profile and clinical features of postinfarction ventricular septal rupture. Seven-year experience at a single center in Russia

    by E. A. Avetisyan, D. V. Pevzner, I. A. Merkulova, A. K. Alieva, L. O. Dulaev, I. T. Zyuryaev, A. D. Levshukov, E. V. Merkulov, A. G. Osiev, A. S. Tereshchenko, et al.

    Aim . To study the clinical and demographic data of a non-selective population of patients with post-infarction ventricular septal rupture (VSR) at a single center in Russia. Material and methods . This single-center, retrospective, observational cohort study included all patients with post-infarction VSR admitted to the Chazov National Medical Research Center of Cardiology in Moscow between 2019 and 2025. Demographics, comorbidities, clinical course, echocardiographic data, frequency and timing of open surgical repair and percutaneous closure, mechanical circulatory support, and patient routing were assessed using descriptive statistics. A search for independent factors influencing the choice of primary intervention was conducted using multiple logistic regression. Results . A total of 94 patients with post-infarction VSR were included in the study between 2019 and 2025. The mean age was 68,5±12 years (women, 56,4%). The most common medical history included hypertension (82/94, 87,2%), diabetes (35/94, 37,2%) and obesity (27/94, 28,7%). An attempt of coronary reperfusion was made in 69,2% of patients (65/94), while only in 28,7% (27/94) it was timely and successful. Cardiogenic shock (CS) occurred in 66% (62/94) of cases, most often stages D 24/62 (38,7%) and E 20/62 (32,3%). Mechanical circulatory support was used in 53,2% of cases. Any curative treatment was performed in 87,2% of cases. Independent predictors of percutaneous closure were pre-intervention CS (8,31 [2,77-24,93], pConclusion . Patients with post-infarction VSR have significant comorbidity. Timely successful coronary reperfusion was achieved in less than a third of patients. A high incidence of end-stage CS is noted, which, along with age over 65,5 years, is an independent predictor of performing percutaneous closure.

  • Coronary physiology indicators for assessing the stenosis functional significance in non-infarct-related arteries in patients with ST-segment elevation myocardial infarction

    by Kh. U. Ibragimova, T. S. Sukhinina, G. K. Arutyunyan, V. A. Klyagina, I. N. Merkulova, V. M. Mironov, N. S. Grishin, A. S. Tereshchenko, E. V. Merkulov, D. V. Pevzner

    Aim . To study the informative value of invasive coronary physiology indices (fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR)) and to evaluate the safety of papaverine as a hyperemic agent to determine the hemodyna­mic significance of stenoses in non-infarction-related arteries (non-IRA) in patients with ST-seg­ment elevation myocardial infarction (STEMI) during the index procedure after primary percutaneous coronary intervention (PPCI). Material and methods . This single-center prospective study included 32 patients over 18 years of age with STEMI and 50-85% stenosis in 38 non-IRA. After PPCI of the infarction-related artery, iFR, contrast-enhanced FFR, and (if there were no contraindications) FFR with papaverine were measured. Rehospitalization was performed 30-45 days later with follow-up coronary angiography and reassessment of physiological parameters. Statistical analysis included Spearman’s rank order coefficient (SRCC), intraclass correlation (ICC), Cohen’s kappa coefficient, Bland-Altman analysis, and McNemar’s test (α=0,05). Results . Analysis of 38 non-IRAs (36 FFR tests with papaverine) demonstrated high reproducibility as follows: iFR — ρ=0,94 (pConclusion . FFR with papaverine and iFR can be safely and informatively used to assess the hemodynamic significance of non-IRA stenoses in hemodynamically stable patients during the first 24 hours after STEMI. The high stability of these parameters during repeated measurements confirms their suitability for dynamic monitoring. Borderline values require careful interpretation and possible use of additional ischemia verification methods.


  • Open Access

    Transient ST-segment elevation in endovascular patent foramen ovale closure: a case report

    by A. S. Tereshchenko, E. V. Merkulov, A. S. Musaev, G. V. Shchelkova

    Introduction . The complication rate of endovascular patent foramen ovale (PFO) closure is considered low. However, for most of complications, the rate has not been precisely determined. The most serious intraoperative complications include damage to the heart wall and vessels with bleeding, malpositioned occlude device, thromboembolism, and air embolism. Reports of severe and potentially fatal complications are rare, making their consideration and the determination of treatment strategies crucial. Brief description . Patient K. aged 36 years had an ischemic stroke. Examination revealed a PFO with significant bypass grafting. Endovascular closure of the PFO was recommended to prevent recurrent ischemic events. During surgery, ST segment elevation was recorded in leads II and III. Selective coronary angiography revealed no contrast enhancement in the distal posterolateral and posterior descending arteries. Intracoronary nitroglycerin was administered, which restored flow in the artery. After the patient's condition stabilized, endovascular closure of the PFO was successfully completed, and an occluder was implanted. Discussion . Possible causes of intraoperative ST segment elevation include gas embolism from air bubbles remaining in the delivery system after flushing, and mechanical irritation of the interatrial septum. Preventive measures include thorough flushing of the delivery system and selection of the occluder size based on heart anatomy.

  • Successful treatment of a patient with left main coronary artery compression due to pulmonary arterial hypertension in HIV infection: a case report

    by V. L. Chitanava, N. S. Grishin, T. V. Martynyuk, E. V. Merkulov, A. S. Tereshchenko

    Human immunodeficiency virus (HIV) is characterized by slow and gradual damage to the immune system. In recent years, its incidence has increased by an average of 10% per year. However, in the era of antiretroviral therapy, the life expectancy of this cohort of patients has increased, shifting the focus to complications, including cardiovascular ones. This article describes a patient with pulmonary arterial hypertension (PAH) associated with HIV infection who developed a rare, severe complication — left main coronary artery compression syndrome due to a dilated pulmonary artery. It describes successful endovascular treatment and the selection of PAH-specific therapy.

  • Ultrasound catheter thrombolysis for the treatment of pulmonary embolism: the first experience in the Russian Federation

    by E.V. Merkulov, A.S. Tereshchenko, G.K. Arutyunyan, D.V. Pevzner, I.T. Zyuryaev, D.V. Skrypnik, A.V. Kostin, O.V. Krestyaninov, A.G. Badoyan, P.I. Pavlov, et al.

    Treatment of pulmonary embolism (PE) is still an urgent problem worldwide due to complications of systemic thrombolytic therapy. This review examines ultrasound catheter thrombolysis using the EKOS system, indications, patient selection and current state of the issue. The device itself, appropriate manipulations and several clinical cases in the Russian Federation are described in detail. The authors described implantation technique and ultrasound thrombolysis.


  • Open Access

    Modern features of coronary thrombosis imaging in non-ST-elevation acute coronary syndrome

    by A. V. Strelkova, M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina, A. V. Yurin, E. V. Gagarina, A. S. Tereshchenko

    Cardiovascular diseases, in particular ST-elevation (STE-ACS) and non-ST-elevation (NSTE-ACS) acute coronary syndrome remain one of the main causes of death worldwide. Published data indicate that in a number of patients, the cause of NSTE-ACS is infarct-related artery occlusion. In modern medicine, there are both invasive and non-invasive coronary thrombosis imaging methods. The aim of the study was to analyze and systematize the literature data on coronary thrombosis imaging methods. The review was prepared using publications indexed in the PubMed, Google Scholar, Web of Science, and Cyberleninka databases. The search depth was 5 years, starting from 2020. The review is based on summarized data from the most relevant clinical studies, reports, and systematic reviews. The conducted literature analysis showed that both invasive and non-invasive imaging methods have a number of advantages and disadvantages. In this regard, improving these techniques remains an urgent research task.


  • Comparison of fluoroscopy and intracardiac echocardiography for control of endovascular closure of patent foramen ovale

    by A.S. Tereshchenko, E.V. Merkulov, G.K. Arutyunyan, O.V. Sapelnikov

    Objective. To compare the results of endovascular closure of patent foramen ovale (PFO) under fluoroscopy and intracardiac echocardiography (ICE). Material and methods. The study included 212 patients who underwent endovascular closure of PFO between 2019 and 2023. The subjects were divided into two groups: fluoroscopy (FS) in 183 patients and ICE in 29 patients. Clinical status of patients was analyzed for 12 months. We estimated technical features of surgery, complications, efficacy of procedure and recurrent adverse events. Results. Surgery time in the ICE group was 40.00 [30.00; 60.00] min, and patients were not exposed to radiation. The occluder was placed in optimal position in all patients. In the FS group, surgery time was 60.00 [45.00; 75.00] min (p=0.0067), radiation time and dose — 612.00 [381.00; 952.50] sec and 9.30 [6.52; 15.12] mSv, respectively. The most serious complications in the FS group were supraventricular tachycardia in 9 (4.92%), mitral valve contact in 1 (0.55%), hemopericardium in 2 (1.09%), and TIA in 1 (0.55%) patient. The length of hospital-stay was 7.00 [4.00; 8.00] days. In the ICE group, we observed vein thrombosis in 1 (3.45%) and body temperature elevation >an 37.1°C in 2 (6.90%) cases. The length of hospital-stay was 5.00 [3.00; 6.00] days (p=0.0016). After 12 months, TIA and ischemic stroke occurred in 2 (0.58%) patients of the FS group, respectively. No vascular catastrophes were recorded in the ICE group. Conclusion. ICE-guided endovascular closure of PFO demonstrated better efficacy and safety.

  • Open Access

    Comparison of long-term and short-term antiplatelet therapy after endovascular closure of patent foramen ovale: a meta-analysis of clinical trial data

    by Andrew S. Tereshchenko, Evgeny V. Merkulov, Mikhail G. Chashchin, Nikita S. Grishin, Anna V. Strelkova, Makka R. Azimova, Andrey L. Komarov, Терещенко Андрей С., Чащин Михаил Г.

    Background. Administration of antiplatelet therapy (APT) is the basis for the prevention of thrombotic complications after endovascular closure of patent foramen ovale (PFO). The 2018 European consensus document on the management of patients with PFO recommended long-term APT. Dual antiplatelet therapy was prescribed for 6 months followed by acetylsalicylic acid (ASC) monotherapy for up to 5 years. Subsequent clinical trials demonstrated a trend towards shorter APT due to the risk of ASC-associated bleeding. In 2022, the SCAI society recommended limiting the duration of APT to 5 months. However, the evidence base is insufficient. Aim. To compare the efficacy and safety of shortened and prolonged APT regimens after endovascular closure of PFO. Materials and methods. Data were searched for the period from January 2017 to May 2024. The primary endpoint was defined as the development of recurrent ischemic stroke (IS). The development of major bleeding was selected as the secondary endpoint. The combined endpoint (CEP) included all-cause death, IS, transient ischemic attack, peripheral thrombosis, myocardial infarction, and major bleeding. Results. Eighty-nine sources were analyzed, of which 3 studies with a total sample of 1870 patients were included in the meta-analysis, which included 731 and 1139 patients with shortened and prolonged APT, respectively. Fatal outcome was recorded in 7 patients receiving abbreviated APT and 6 patients receiving prolonged APT. Patients in both groups had a comparable risk of mortality (RR 1.97; 95% CI 0.59–6.57; p=0.24; I2=29%). Similar results were obtained for the risk of TIA (RR 1.02; 95% CI 0.43 to 2.42; p=0.41; I2=0%), for the risk of IS (RR 1.01; 95% CI 0.41–2.49; p=0.59; I2=0%), and for minor bleeding (RR 0.81; 95% CI 0.49–1.34; p=0.24; I2=29%). CEP was achieved in 26 patients receiving abbreviated APT and 39 patients receiving prolonged APT; the risk of CEP did not significantly differ between combined endpoints (RR 1.04; 95% CI 0.63–1.72; p=0.15; I2=48%). Discussion. The results of the meta-analysis showed that there was no statistical difference between abbreviated and prolonged APT in terms of efficacy and safety, which is consistent with previous clinical studies. Conclusion. Abbreviated APT can be considered as the strategy of choice in patients at high risk of bleeding and in the absence of risk factors for thromboembolism. Conducting new studies will make it possible to accurately determine the duration of APT and develop clinical recommendations with a convincing evidence base.